Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 192,180 | 32,811 | 60,391 | 65,985 | 48,633 |
| Gross Profit | 192,180 | 32,811 | 60,391 | 65,985 | 48,633 |
| Operating Expenses | 70,998 | 54,958 | 51,704 | 35,330 | 27,986 |
| Operating Income | 121,182 | -22,147 | 8,687 | 30,655 | 20,647 |
| Other Income | 50 | 53 | 52 | 58 | 9 |
| Pre-tax Income | 121,232 | -22,094 | 8,739 | 30,713 | 20,656 |
| Income Tax | 4,100 | 6,100 | 7,200 | N/A | 0 |
| Net Income Continuous | 117,132 | -28,194 | 1,539 | 30,713 | 20,656 |
| Net Income | $117,132 | $-28,194 | $1,539 | $30,713 | $20,656 |
| EPS Basic Total Ops | 1.41 | -0.34 | 0.02 | 0.37 | 2.62 |
| EPS Basic Continuous Ops | 1.41 | -0.34 | 0.02 | 0.37 | 2.62 |
| EPS Diluted Total Ops | 1.35 | -0.34 | 0.02 | 0.34 | 2.62 |
| EPS Diluted Continuous Ops | 1.35 | -0.34 | 0.02 | 0.34 | 2.62 |
| EBITDA(a) | $121,189 | $-22,140 | $8,695 | $30,662 | $20,653 |